Doximity (DOCS) ended the recent trading session at $58.18, demonstrating a +0.61% swing from the preceding day's closing price. The stock's change was less than the S&P 500's daily gain of 0.73%. At the same time, the Dow added 0.16%, and the tech-heavy Nasdaq gained 0.98%.Prior to today's trading, shares of the medical social networking site had gained 19.98% over the past month. This has outpaced the Medical sector's loss of 3.8% and the S&P 500's gain of 0.34% in that time.The investment community will ...

The healthcare sector experienced a dynamic year, shaped by factors such as rising patient volumes, higher occupancy rates, escalating medical costs, inflationary pressures and the resumption of elective procedures, particularly among seniors. Key trends, including the increasing use of artificial intelligence (AI), an aging population, a rise in chronic diseases and advancements in personalized medicine, are expected to persist into 2025, driving further transformation.The sector is undergoing significant ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Doximity (DOCS) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.Doximity is a member of the Medical sector. This group includes 1022 individual stocks and currently holds a Zacks Sector Rank of #3. The Zacks S ...

The broader U.S. equity markets have witnessed significant volatility over the past few trading days as the post-election rally fizzled due to concerns regarding potential policy shifts under the new administration. The markets were further weighed down by apprehensions about the pace of interest rate cuts as healthy economic growth offered some leeway to go slow on the proposed monetary easing. However, solid earnings from blue-chip technology stocks helped markets recover some lost ground. With NVIDIA res ...

Doximity (DOCS) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its earnings outlook is still improving.The upward trend in estimate revisions for this medical social networking site reflects growing optimism of analysts on its earnings prospects, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings est ...

Doximity calls themselves the digital platform for doctors. They offer an integrated suite of tools that enables marketing, staffing, and workflow management tools including telehealth, scheduling, and document management. More than 90% ofMichael (Mike) Dion is an FP&A, Corporate Finance, and Small Business expert who spent the last 12 years working in the Fortune 100, building a startup's finance and accounting department, advising small businesses, and guiding non-profit organizations as a board member. H ...

Key TakeawaysDoximity shares surged Friday morning after the company's second quarter results and outlook for the rest of its fiscal year beat estimates.The company said over 600,000 medical professionals used its networking and productivity tools in the quarter.Doximity's third-quarter revenue projections beat estimates, and the company lifted its full-year outlook for revenue. Doximity (DOCS) shares jumped nearly 40% in premarket trading Friday after the medical tech company's earnings and outlook came in ...

INVESTOR PRESENTATION Fall 2024 LEGAL DISCLAIMER This presentation and associated commentary may contain forward-looking statements, including statements regarding expectations of future results of operations or financial performance of Doximity, market size and growth opportunities, the calculation of certain of our key financial and operating metrics, capital expenditures, plans for future operations, competitive position, technological capabilities, and strategic relationships, general business condition ...

Doximity, Inc. (NYSE:DOCS) Q2 2025 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Perry Gold - Vice President of Investor Relations Jeff Tangney - Co-Founder and CEO Anna Bryson - Chief Financial Officer Nate Gross - Co-Founder and Chief Strategy Officer Conference Call Participants Glen Santangelo - Jefferies Johnathan McCary - Raymond James Stephanie Davis - Barclays Jared Haase - William Blair Elizabeth Anderson - Evercore ISI Allen Lutz - Bank of America Dan Clark - Leerink Sc ...

Doximity (DOCS) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.22 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 15.38%. A quarter ago, it was expected that this medical social networking site would post earnings of $0.22 per share when it actually produced earnings of $0.28, delivering a surprise of 27.27%.Over the last four quarte ...